MONT SAINT-HILAIRE, April 18 /PRNewswire-FirstCall/ - Axcan Pharma Inc. (“Axcan” or the “Company”) today announced that on Tuesday, April 25th, 2006, President and Chief Executive Officer, Frank A.G.M. Verwiel, M.D., will present an overview of the Company at the UBS Global Specialty Pharmaceuticals Conference to be held in New York, NY. This presentation will take place at 1:30 p.m. (Eastern time).
A live webcast of Axcan’s presentation will also be accessible via the Company’s website at www.axcan.com.
Axcan is a leading specialty pharmaceutical company involved in the field of gastroenterology. The Company markets a broad line of prescription products sold for the treatment of symptoms in a number of gastrointestinal diseases and disorders such as inflammatory bowel disease, irritable bowel syndrome, cholestatic liver diseases and complications related to cystic fibrosis. Axcan’s products are marketed by its own sales force in North America and Europe. Its common shares are listed on the Toronto Stock Exchange under the symbol “AXP” and on the NASDAQ National Market under the symbol “AXCA”.
AXCAN PHARMA INC.
CONTACT: Isabelle Adjahi, Director, Investor Relations, Axcan Pharma Inc.,(450) 467-2600 ext. 2000; Web: www.axcan.com; Source: AXCAN PHARMA INC.; Torequest a free copy of this organization’s annual report, please go tohttp://www.newswire.ca and click on reports@cnw
